Magenta Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Summary

Magenta Therapeutics (Nasdaq: MGTA) will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 4:40 p.m. ET. A live webcast will be available on their website, with a replay accessible for 90 days post-event. Magenta focuses on developing novel medicines utilizing the curative potential of stem cell transplants for patients with blood cancers, genetic disorders, and autoimmune diseases. The company combines expertise in stem cell biology with a unique business model to transform immune resetting treatments.

Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company is scheduled to participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 4:40 p.m. ET.

A live webcast of the fireside chat can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210603005121/en/

FAQ

When is Magenta Therapeutics participating in the Goldman Sachs 42nd Annual Global Healthcare Conference?

Magenta Therapeutics will participate on June 10, 2021, at 4:40 p.m. ET.

How can I watch the Magenta Therapeutics fireside chat?

The fireside chat can be accessed via a live webcast on the Magenta Therapeutics website.

What is the focus of Magenta Therapeutics?

Magenta Therapeutics specializes in developing medicines that leverage stem cell transplants for patients with blood cancers, genetic diseases, and autoimmune conditions.

Where is Magenta Therapeutics based?

Magenta Therapeutics is based in Cambridge, Massachusetts.

Is there a replay available for the Magenta Therapeutics fireside chat?

Yes, a replay of the fireside chat will be available for 90 days following the event.